TY - JOUR T1 - First detection and report of SARS-CoV-2 Spike protein N501Y mutations in Oklahoma USA JF - medRxiv DO - 10.1101/2021.01.26.21250584 SP - 2021.01.26.21250584 AU - Sai Narayanan AU - Girish Patil AU - Sunil More AU - Jeremiah Saliki AU - Anil Kaul AU - Akhilesh Ramachandran Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/01/29/2021.01.26.21250584.abstract N2 - We describe the detection of SARS-CoV-2 (VOC)B.1.1.7 lineage in Oklahoma, USA. Various mutations in the S gene and ORF8 with similarity to the genome of B.1.1.7 lineage were detected in 4 of the 6 genomes sequenced and reported here. The sequences have been made available in GISAID. Presence of novel lineages indicate the need for frequent whole genome sequencing to better understand pathogen dynamics in different geographical locations.Competing Interest StatementThe authors have declared no competing interest.Funding StatementStudy was partially funded by FDA-CVM-VetLIRN (Grant no.5U18FD006671-02).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Institutional Review Board (Application number: IRB-20-357) at Oklahoma State University, Stillwater OK 74078, United States.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSequence data has been made available in GISAID (www.gisaid.org). The accession numbers for the sequences have been provided in the manuscript. http://www.gisaid.org ER -